NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- Researchers Caught in Crossfire as High-Resolution Spatial Technology Providers Wage Turf War
- Congress Introduces Bill to Prevent Medical Providers From Using BGI, MGI and Affiliates' Products
- BGI Group Addresses Accusations in Proposed US Biosecure Act
- Trial Failure Raises Questions About MRD Testing Utility, but Prognostic Evidence Remains Strong
- NCCN Calls ctDNA Emerging Colon Cancer Prognostic Marker, Does Not Back Use Outside Clinical Trials